Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SM

Stanton McHardy — 23 Patents

Pfizer: 9 patents #561 of 5,153Top 15%
University Of Texas System: 6 patents #431 of 6,559Top 7%
CPCurtana Pharmaceuticals: 4 patents #3 of 8Top 40%
SISouthwest Research Institute: 3 patents #198 of 935Top 25%
UTUniversity Of Texas: 1 patents #37 of 278Top 15%
Helotes, TX: #13 of 216 inventorsTop 7%
Texas: #5,758 of 125,132 inventorsTop 5%
Overall (All Time): #178,160 of 4,157,543Top 5%
23 Patents All Time
Stanton McHardy has been granted 23 US patents while listed as an inventor at Pfizer. The first was granted in 2002 and the most recent in July 2025. Stanton McHardy ranks #178,160 of 4,157,543 US inventors in our database (top 4.3%). Patent records list Stanton McHardy in Helotes, TX, US.

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12358909 Capsazepine analogs for the treatment of cancer and other proliferative diseases Cara B. GONZALES 2025-07-15
12145913 Inhibition of Olig2 activity Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang 2024-11-19
12071409 Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof Stanley Watowich, Harshini Neelakantan, Hua Wang 2024-08-27
11952330 Antibiotic ammonium compounds and methods for the treatment of bacterial infections Bryan Davies, Ashley Cunningham, Hua Wang 2024-04-09
11691951 Inhibition of Olig2 activity Graham Beaton, Fabio Tucci, Satheesh B. Ravula, Francisco Xavier RUIZ, Ambrosio Lopez, Jr. +2 more 2023-07-04
11685722 Inhibition of Olig2 activity Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang 2023-06-27
11492331 Redox substrates for leukocyte esterase Waldemar Gorski, Douglas Hanson, Travis Menard, Andrew FLEISCHMAN 2022-11-08
11401243 Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof Stanley Watowich, Harshini Neelakantan, Hua Wang 2022-08-02
11304916 Methods and compositions for the treatment of Shiga Toxicosis Somshuvra Mukhopadhyay, Andrey S. Selyunin 2022-04-19
11242323 Inhibition of OLIG2 activity Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang 2022-02-08
10457676 Capsazepine analogs for the treatment of cancer and other proliferative diseases Cara B. GONZALES 2019-10-29
9169220 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben 2015-10-27
8772345 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben 2014-07-08
8653108 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben 2014-02-18
8124639 Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors John A. Lowe, III 2012-02-28 $631,730,000
RE40838 2-azabicyclo[3.3.1]nonane derivatives Jotham Wadsworth Coe 2009-07-07
7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors John A. Lowe, III 2009-01-06 $204,330,000
7241887 3-azabicyclo[3.2.1]octane derivatives Jotham Wadsworth Coe, Crystal G. Bashore 2007-07-10 $150,041,000
7129263 Preparation of 3-azabicyclo [3.1.0] hexane derivatives John Ragan, Derek Tickner, Brian C. Vanderplas, Jotham Wadsworth Coe 2006-10-31
7056930 2-Azabicyclo[3.3.1]nonane derivatives Jotham Wadsworth Coe 2006-06-06 $125,956,000
7049335 3-azabicyclo[3.1.0]hexane derivatives Spiros Liras, Steven Heck 2006-05-23 $424,328,000
6960609 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands Michael Vetelino 2005-11-01 $296,391,000
6444679 4-phenyl-4-heteroarylpiperidine derivatives Spiros Liras 2002-09-03 $340,645,000